Sunifiram, also known as DM-235, is a piperazine derivative of Piracetam that is commonly associated with Racetam compounds even though they are technically not part of that particular class. It has been shown to have nootropic effects in animal test subjects; according to scientific studies, these effects are noted to be stronger than Piracetam. Currently, it is set aside for research study only.